Human medicines European public assessment report (EPAR): Revlimid, lenalidomide, Date of authorisation: 14/06/2007, Revision: 54, Status: Authorised

Submitted by Anonymous (not verified) on 9 September 2025 - 15:55

Human medicines European public assessment report (EPAR): Revlimid, lenalidomide, Date of authorisation: 14/06/2007, Revision: 54, Status: Authorised

Orphan designation: botaretigene sparoparvovec Treatment of inherited retinal dystrophies due to defects in the RPGR gene, 23/07/2025 Positive

Submitted by Anonymous (not verified) on 9 September 2025 - 14:59

Orphan designation: botaretigene sparoparvovec Treatment of inherited retinal dystrophies due to defects in the RPGR gene, 23/07/2025 Positive

Human medicines European public assessment report (EPAR): Ecalta, anidulafungin, Date of authorisation: 20/09/2007, Revision: 27, Status: Authorised

Submitted by Anonymous (not verified) on 9 September 2025 - 14:57

Human medicines European public assessment report (EPAR): Ecalta, anidulafungin, Date of authorisation: 20/09/2007, Revision: 27, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness